A new way to deliver chemotherapy shows less side effects, comes to Nebraska

OMAHA, Neb. (KLKN) – More than 67,000 Americans are diagnosed with pancreatic cancer, or ‘the silent killer’, each year. When diagnosed late, chemotherapy means a lot of nausea, vomiting and increased risk to infection, but thanks to the innovative process of TAMP, Trans-Arterial Micro-Perfusion, pancreatic cancer chemo patients may have less side effects. The Renovo Cath device is making TAMP...